Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy
Technology
E-275-2002
Patent ID
E-275-2002-1-US-02
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
8034334
Publication Number
US-2006-0165652-A1
Application Number
10/526,697
IC
NCI
Date Filed
Date Issued